Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
Completed · Phase 2 · Has a placebo group
Conditions studied: Central Neuropathic Pain, Multiple Sclerosis
In brief
The objectives of the study are to evaluate the safety, tolerability, and efficacy of 3 doses of AVP-923 capsules in the treatment of central neuropathic pain in participants with multiple sclerosis.
Key facts
- Study ID
- NCT01324232
- Run by
- Avanir Pharmaceuticals
- People needed
- 209
- Starts
- 2011-09-08
- Expected to finish
- 2013-09-26
- Last updated by the study team
- 2021-11-22
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- St. Joseph's Hospital Medical Center — Phoenix, Arizona, United States
- Alta Bates Summit Medical Center — Berkeley, California, United States
- University of California, Irvine — Orange, California, United States
- Coordinated Clinical Research — San Diego, California, United States
- University of California, San Francisco — San Francisco, California, United States
- University of Colorado — Aurora, Colorado, United States
- Neurology Associates, PA — Maitland, Florida, United States
- Collier Neurologic Specialists — Naples, Florida, United States
- Laszlo J. Mate, MD — North Palm Beach, Florida, United States
- Neurology Associates of Ormond Beach — Ormond Beach, Florida, United States
- Neurological Associates — Pompano Beach, Florida, United States
- Neurologique Foundation — Ponte Vedra Beach, Florida, United States
- Suncoast Neuroscience Associates, Inc. — St. Petersburg, Florida, United States
- University of South Florida — Tampa, Florida, United States
- Geodyssey Research, LLC — Vero Beach, Florida, United States
- Shepard Center — Atlanta, Georgia, United States
- Rush-Presbyterian St. Luke's Medical Center — Chicago, Illinois, United States
- Consultants in Neurology — Northbrook, Illinois, United States
- Josephson Wallack Munshower Neurology, P.C. — Indianapolis, Indiana, United States
- MidAmerica Neuroscience Institute — Lenexa, Kansas, United States
- Johns Hopkins University School of Medicine — Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Michigan Neurology Associates, P.C. — Clinton Township, Michigan, United States
- Wayne State University — Detroit, Michigan, United States
- North Central Neurology Associates PC — Cullman, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.